Deep-Learning Analysis of Peripheral Blood Smear for Prediction of Acute Inflammatory States and Chronic Comorbidities: Development and Internal Validation Study

Background: Peripheral blood smear (PBS) examination provides morphological information on immune cells that reflects systemic pathophysiology, yet whether it can be used to predict systemic states has not been systematically established. Objective: This study aimed to develop and evaluate an integrated deep learning framework that leverages cell-level morphology from routine PBS examinations to discriminate acute inflammatory states and chronic comorbidities. Methods: An integrated deep learning framework was developed for PBS analysis, in which cell-level morphological features were extracted and aggregated into slide-level representations to predict systemic states. A total of 51,369 PBS examinations were used for self-supervised cell-level pretraining and 9211 for slide-level downstream tasks. Outcomes comprised acute inflammatory states and chronic comorbidities. Acute inflammatory states included white blood cell (WBC) count (categorized as low, normal, or high), elevated C-reactive protein (CRP), elevated erythrocyte sedimentation rate (ESR), and septic shock. Chronic comorbidities included the Charlson Comorbidity Index (CCI), cardiovascular disease (CVD), chronic kidney disease (CKD), and diabetes mellitus (DM). Discriminative performance was assessed using the area under the receiver operating characteristic curve (AUROC) with 95% CIs, computed on the test set of the development dataset and on the holdout dataset. The framework was compared with a demographic model based on age and sex and with a cell-type-only model without morphological features. As a secondary analysis, temporal validation was performed using a chronological split. Results: The framework discriminated acute inflammatory states, achieving development and holdout AUROCs of 0.852 (95% CI 0.836-0.867) and 0.849 (0.833-0.864) for WBC count, 0.891 (0.870-0.913) and 0.896 (0.876-0.915) for CRP, 0.838 (0.794-0.878) and 0.844 (0.799-0.882) for ESR, and 0.849 (0.807-0.886) and 0.822 (0.783-0.853) for septic shock. Discrimination of chronic comorbidities was more modest but consistent across the 2 datasets, with AUROCs of 0.792 (0.762-0.818) and 0.781 (0.751-0.808) for CCI, 0.696 (0.665-0.727) and 0.680 (0.654-0.708) for CVD, 0.724 (0.690-0.755) and 0.728 (0.696-0.756) for CKD, and 0.645 (0.610-0.680) and 0.638 (0.603-0.674) for DM. The framework significantly outperformed the cell-type-only model for all outcomes in both datasets but did not significantly outperform the demographic model for CVD in the holdout dataset or for DM in either dataset. AUROCs in the temporal holdout dataset ranged from 0.621 for DM to 0.883 for CRP, consistent with those in the temporal development test set (0.666 to 0.889). Conclusions: An integrated deep learning framework for automated PBS analysis can provide information associated with inflammation-related laboratory results and clinical outcomes, with stronger discrimination for acute inflammatory states than for chronic comorbidities. These exploratory findings suggest the potential of deep learning-based PBS analysis as a novel approach to assessing systemic states in clinical practice.

Authors

Institutions

Publication Details

Journal
JMIR Medical Informatics
Published
2026-11-13
DOI
https://doi.org/10.2196/100445
Primary Topic
Digital Imaging for Blood Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Deep-Learning Analysis of Peripheral Blood Smear for Prediction of Acute Inflammatory States and Chronic Comorbidities: Development and Internal Validation Study

Yu Rang Park, Jaehyeok Jang, Jaewoo Song, Min-Su Lee
4 links
JMIR Medical Informatics
Digital Imaging for Blood Diseases
article

Deep-Learning Analysis of Peripheral Blood Smear for Prediction of Acute Inflammatory States and Chronic Comorbidities: Development and Internal Validation Study

Yu Rang Park, Jaehyeok Jang, Jaewoo Song, Min-Su Lee
article en

Abstract

Background: Peripheral blood smear (PBS) examination provides morphological information on immune cells that reflects systemic pathophysiology, yet whether it can be used to predict systemic states has not been systematically established. Objective: This study aimed to develop and evaluate an integrated deep learning framework that leverages cell-level morphology from routine PBS examinations to discriminate acute inflammatory states and chronic comorbidities. Methods: An integrated deep learning framework was developed for PBS analysis, in which cell-level morphological features were extracted and aggregated into slide-level representations to predict systemic states. A total of 51,369 PBS examinations were used for self-supervised cell-level pretraining and 9211 for slide-level downstream tasks. Outcomes comprised acute inflammatory states and chronic comorbidities. Acute inflammatory states included white blood cell (WBC) count (categorized as low, normal, or high), elevated C-reactive protein (CRP), elevated erythrocyte sedimentation rate (ESR), and septic shock. Chronic comorbidities included the Charlson Comorbidity Index (CCI), cardiovascular disease (CVD), chronic kidney disease (CKD), and diabetes mellitus (DM). Discriminative performance was assessed using the area under the receiver operating characteristic curve (AUROC) with 95% CIs, computed on the test set of the development dataset and on the holdout dataset. The framework was compared with a demographic model based on age and sex and with a cell-type-only model without morphological features. As a secondary analysis, temporal validation was performed using a chronological split. Results: The framework discriminated acute inflammatory states, achieving development and holdout AUROCs of 0.852 (95% CI 0.836-0.867) and 0.849 (0.833-0.864) for WBC count, 0.891 (0.870-0.913) and 0.896 (0.876-0.915) for CRP, 0.838 (0.794-0.878) and 0.844 (0.799-0.882) for ESR, and 0.849 (0.807-0.886) and 0.822 (0.783-0.853) for septic shock. Discrimination of chronic comorbidities was more modest but consistent across the 2 datasets, with AUROCs of 0.792 (0.762-0.818) and 0.781 (0.751-0.808) for CCI, 0.696 (0.665-0.727) and 0.680 (0.654-0.708) for CVD, 0.724 (0.690-0.755) and 0.728 (0.696-0.756) for CKD, and 0.645 (0.610-0.680) and 0.638 (0.603-0.674) for DM. The framework significantly outperformed the cell-type-only model for all outcomes in both datasets but did not significantly outperform the demographic model for CVD in the holdout dataset or for DM in either dataset. AUROCs in the temporal holdout dataset ranged from 0.621 for DM to 0.883 for CRP, consistent with those in the temporal development test set (0.666 to 0.889). Conclusions: An integrated deep learning framework for automated PBS analysis can provide information associated with inflammation-related laboratory results and clinical outcomes, with stronger discrimination for acute inflammatory states than for chronic comorbidities. These exploratory findings suggest the potential of deep learning-based PBS analysis as a novel approach to assessing systemic states in clinical practice.

JMIR Medical InformaticsVol. 14
Yonsei University (KR)
Good health and well-being
Digital Imaging for Blood Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon